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Earlier studies have established  a  murine model for human chronic lymphocytic 
thyroiditis by demonstrating the effects of injecting mouse thyroglobulin (MTg)1 with 
either complete Freund's adjuvant (CFA) (1-3) or lipopolysaccharide (4). The exper- 
imental  autoimmune  thyroiditis  (EAT)  requires  T  cells  for  its  induction  in  high 
responder mice. The H-2-1inked responsiveness to MTg is encoded by the I-A subregion 
(5). Moreover, recent investigations (6-9) have provided evidence for the existence of 
T  cells  reactive with  this  self-antigen.  Lymph node T  cells  from  immunized high 
responder  mice proliferated  in  culture  upon  MTg stimulation  in  vitro  (7,  8).  The 
proliferative response was maximal 8-14 d  after immunization. It serves as an early 
in  vitro  indicator of subsequent  lymphocytic infiltration  into  the  thyroids of high 
responder  mice,  because  similarly  immunized  low  responder  mice  displayed  little 
blastogenesis  and  thyroid  damage.  Furthermore,  thyroglobulin-specific T  cells  re- 
sponded to repeated injections of soluble, syngeneic MTg (9);  even in the absence of 
adjuvant,  all  the  animals  produced autoantibodies  and  ~50%  had  thyroid lesions. 
Studies by others (10, 11) also showed that lymph node T cells cultured from syngeneic 
thyroid monolayers became blastogenic. We conclude from these findings that EAT 
is initiated by autoreactive T  cells with receptors for MTg. Because suppressor T  cells 
can also be activated by soluble,  native MTg (12),  we further suggest that  EAT is 
regulated by the clonal balance of T  cell subpopulations (13). 
Despite the known immunologic manifestations of the disease in both the mouse 
and human, the regulatory mechanisms and the interplay of T  cell subsets  in EAT 
are  difficult  to  dissect.  One  prime  reason  is  that  the  effector  mechanisms  that 
culminate in tissue damage are complex. A  second reason has been our inability to 
measure thyroid damage in vitro. We therefore initiated studies in vitro on the effector 
mechanisms of EAT by establishing functional thyroid monolayers suitable for use as 
target cells. We report here the first demonstration of effector cells that are cytotoxic 
for thyroid monolayers and their T  cell characteristics. 
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Materials  and  Methods 
Animals.  Female CBA/J  (1-1-2  k)  mice were purchased from The Jackson Laboratory, Bar 
Harbor, ME and immunized when 8-10 wk old. For syngfneic and allogeneic thyroid cultures, 
3-5-mo-old  male  and  female  CBA  and  BALB/c  (H-2)  mice  were  used.  These  CBA  and 
BALB/c mice were inbred in our colonies and originated from The Jackson Laboratory and 
Cumberlandview Farms, Clinton, TN, respectively. 
Immumzation.  MTg was prepared  from  frozen mouse thyroids, kindly supplied by Dr.  C. 
David (Mayo Medical School, Rochester,  MN), and purified by column chromatography as 
previously described  (14).  CBA/J  mice were  immunized with MTg  (or saline) emulsified in 
CFA (Difco Laboratories, Detroit, MI) at a  1:1 ratio, as detailed earlier (8); a  total of 120 #g 
MTg in 0.2 ml was given at four sites (both hind footpads and thighs). 
Antisera and Complement.  Anti-Thy-1.2 (immunoglobulin M  [IgM]), anti-Lyt-1.1 (IgG), and 
anti-Lyt-2.1 (IgG) monoclonal mouse antibodies were purchased from Cedarlane Laboratories, 
Hornby, Ontario, Canada. Rabbit antiserum to mouse Ig, purchased from Miles Yeda Ltd., 
Rehovot, Israel, was used as an amplifying serum. Guinea pig complement was obtained from 
Grand Island Biological Co., Grand Island, NY. Mouse antiserum specific for H-2K k products 
was prepared by immunizing (BALB/c ×  A.TL)F1 mice repeatedly with A/J-derived thymo- 
cytes; mouse antiserum specific tbr H-2D k molecules was prepared  by immunizing (BALB/c 
X A.AL)F1 mice repeatedly with BALB.k thymocytes. These antisera were kindly supplied by 
Dr. K. W. Beisel, formerly of the Department of Immunology and Microbiology, Wayne State 
University School  of Medicine. Antiserum to  MTg was raised  in rabbits by subcutaneously 
injecting MTg in CFA three times at 4-wk intervals (2.0,  1.7, and 0.8 mg MTg in 1.0 ml CFA 
at multiple sites). Final bleedings were obtained 1 mo after the last injection and the sera were 
pooled on the basis of high titers of precipitins to MTg. The rabbit antiserum to MTg was 
diluted 1  : 10, and absorbed with either MTg-coated erythrocytes (4) or CBA spleen cells at 4°C 
for 30 min, with  1/10 vol of packed cells. 
Tissue  Culture Media.  Unless specified otherwise,  tissue culture medium and supplements 
were purchased from Gibco Laboratories. The basic supplements for RPMI  1640 were 25 mM 
Hepes, 2 mM glutamine, penicillin (100 U/ml), and streptomycin (100 p~g/ml). For lymphocyte 
cultures, additional supplements were 50/~M 2-mercaptoethanol (Eastman Kodak Co., Roch- 
ester, NY) and 1% fetal calf serum (FCS). For the cytotoxicity assay, 5% FCS was used with 50 
#M  2-mercaptoethanol.  For  thyroid  cell  cultures,  additional  supplements  were  10%  FCS, 
fungizone (2.5  #g/ml), gentamicin (100 ktg/ml; Schering Corp., Kenilworth, NJ),  and  1 "~M 
NaI. Batches of FCS were heat inactivated at 56°C for 45 min and selected for each procedure. 
Thyroid Cell Cultures.  Thyroids were processed by a  modification of the procedure of Yeni 
and Charreire  (10).  CBA or BALB/c mice were killed by cervical dislocation and dipped in 
50%  ethanol. The  thyroids were  removed aseptically and minced with  fine scissors  in 5  ml 
Hanks' balanced salt solution (HBSS) that contained 1.5 mg/ml collagenase (Sigma Chemical 
Co.,  St.  Louis, MO). After a  15-min incubation period at  37°C, the thyroid suspension was 
vigorously pipetted; this procedure was repeated two more times with incubation periods of 10 
min until a  homogeneous suspension of partially disrupted  follicles was obtained. Next,  the 
thyroid suspension was diluted to 15 ml with HBSS that contained 20% FCS, and washed three 
times by centrifugation at  200 g  for  10 min with  HBSS  containing 10%  FCS.  It  was  then 
resuspended in thyroid culture medium and dispensed into flat-bottomed 96-well microplates 
(100 #l/well). On the following day, nonadherent cells were removed by washing the plates 
twice with HBSS; fresh culture medium was added and was renewed every 3rd d. Because the 
concentration of thyroid  cells  in the  suspension was  difficult to  quantitate,  the  number of 
thyroids used was taken as a  measure. In general, on day 5 of culture, a confluent monolayer 
was  obtained with  a  thyroid  suspension prepared  from  12  mice  per  microplate.  Confluent 
growth was not achieved with <10 thyroid donors per plate. To obtain functional thyroid cells, 
culture medium was supplemented with 1 mM dibutyryl adenosine 3',5'-cyclic monophosphate 
(cAMP)  (Sigma Chemical Co.)  and 60 /~U/ml thyroid-stimulating hormone  (TSH)  (Sigma 
Chemical Co.). These concentrations are optimal, as presented in the Results section. Thyroid 
function was measured by comparing MTg concentration in tissue culture supernatants and 
cell extracts.  Proteins from the cells were extracted with a buffer containing 5 mM Tris HC1, 
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fluoride and  5  mM  iodoacetamide).  Supernatants  were collected at  different  intervals after 
culture. The samples were dialyzed in 0.05 M  NH4HCOa, lyophilized, and reconstituted with 
200  pl  phosphate-buffered  saline  containing  0.5%  Tween  20.  The  amount  of  MTg  was 
determined by the enzyme-linked immunosorbent assay (ELISA). 
Lymphocyte Cultures.  On  days  12-18  after  immunization,  lymph  node  cells  (LNC)  were 
prepared  from  inguinal  and  popliteal lymph  nodes  by dispersion  through  80-mesh  stainless 
steel screens.  After three washings  by centrifugation  in HBSS, the cells were resuspended  in 
culture medium at a  concentration of 2 ×  106/ml. For stimulation with MTg, doses of 10-50 
pg/ml were tried. Bovine serum albumin  (BSA) (fraction V; Miles Laboratories Inc., Elkhart, 
IN) served as a control antigen. LNC were then incubated at 37°C in a  humidified incubator 
containing 5% CO2 in air. The eytotoxieity assay was performed on day 5 of culture when LNC 
viability determined by trypan-blue exclusion was ~75%. To deplete lymphocyte subpopula- 
tions, aliquots of MTg-stimulated LNC in HBSS (1 X  107/ml) were incubated with monoclonal 
antibodies to either Thy-l.2  (1:50),  Lyt-l.1  (1:20),  or Lyt-2.1  (1:20)  for 45 min at 4°C. After 
one washing, the cells were resuspended to the same concentration and incubated with rabbit 
antiserum to mouse Ig (1:300) for 45 min at 4oc. After washing, the cells were further incubated 
with  guinea  pig  complement  at  nontoxic  dilutions  (_~1:32)  for  1  h  at  37°C.  After a  final 
washing, the cells were either recultured for 24 h or tested immediately for cytotoxicity against 
thyroid cells. 
Cytotoxicity Assay.  Thyroid monolayers were labeled with indium-111  (UaIn) by incubation 
Ill  111  with 50/~1 of  In-oxine (12 pCi/ml) in HBSS for 10 min at room temperature.  In-oxine was 
111  either prepared from  In-chlomde (Medi-Physics, Inc., South Plainfield, N  J) as described by 
Frost et al.  (15)  or obtained directly from Amersham Corp., Arlington Heights, IL. After one 
washing with HBSS that  contained  10% FCS, the thyroid cells were incubated  for 30 min at 
37°C, which reduced the background level of radioactivity. After two additional washings, the 
1lain-labeled thyroid cells were used as targets for in vitro-stimulated LNC. First, 0.1  ml/well 
of cytotoxicity medium was added.  LNC cultured with MTg for 5 d  in vitro were resuspended 
at 2 X  106/ml  (except where indicated otherwise)  in the cytotoxicity medium and 0.1  ml was 
added to the labeled target cells in each well. Each determination was performed in quadru- 
plicate. The plates  were incubated  overnight  (16 h)  at  37°C in an  incubator  containing 5% 
CO2 in air. The supernatants  (150 pl) were carefully removed from each well, and radioactivity 
was  counted  in  a  gamma-scintillation  counter  (Nuclear-Chicago  Corp.,  Des  Plaines,  IL). 
Maximal  lysis was  determined  after the addition  of 1 N  HCI to  target  cells cultured  in  the 
presence of medium only; radioactivity usually ranged from 50 to 75 X  103 cpm. Spontaneous 
release usually ranged from 8 to  10 X  103 cpm or 12-19% of the maximum value. ×11In-release 
was calculated from the formula: percent specific release -- (experimental release -  spontaneous 
release) cpm/(maximal release -  spontaneous release) cpm ×  100.  The statistical significance 
of the difference between control and experimental groups was calculated with the two-tailed 
Student's t test. 
When  target cells were pretreated  with antisera  (mouse antiserum  to K k or D k, or rabbit 
antiserum to MTg), appropriate dilutions were added after the first washing following labeling. 
Incubation  was for  1 h  at  37°C and  was  followed by two additional washings.  The test  was 
then performed as described above. 
MTg Determination.  The concentrations  of MTg  in  thyroid  culture  supernatants  and  cell 
extracts were determined by the ELISA developed in our laboratory according to established 
procedures (16).  Both coating antibody (AN-24) and alkaline phosphatase-conjugated antibody 
(D-3) to MTg were obtained from mouse hybridoma lines that were selected from a panel of 18 
clones (17,  18). The two clones produced antibodies to different mouse-specific determinants of 
MTg and  were propagated  in ascitic form.  Antibodies  in the ascitic fluids were purified  by 
ammonium sulfate precipitation. The antibodies and MTg used for the standard curve and the 
conjugate were ultracentrifuged at 100,000 g for 1 h before testing; all samples were centrifuged 
at 8,000 g for 2 min. The sensitivity of the test was  10-20 ng MTg/ml. 
Results 
Propagation of Functional Thyroid Monolayers.  The addition of TSH  and/or  cAMP  to 
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activate thyroid cells (19-21).  Activation has  been  measured  by iodide uptake  (19, 
20), the release of 3,5,3'-triiodothyronine and  thyroxine (20)  and thyroglobulin (21) 
into the culture medium, and changes in membrane potential (19). We first measured 
mSI-uptake of mouse thyroid cells in culture after the addition of TSH  and observed 
little influence on the amount of incorporation (data not shown). We next determined 
MTg  production  after  the  addition of varying amounts  of cAMP  to  the  medium. 
Supernatants  from  five wells of a  microplate, which  contained  cells from  approxi- 
mately half a  thyroid gland, were pooled on day 3 of culture. The cells were washed 
three  times  with  medium  and  the  cell  proteins  were  extracted  with  buffer.  After 
dialysis and concentration by lyophilization, the amounts of MTg in the samples were 
determined by ELISA; three to five twofold dilutions were tested for each sample. As 
shown in Fig. 1, thyroid cells cultured in medium without cAMP contained negligible 
amounts  of MTg.  The  amount  of MTg  recovered  from  the  cell extracts  increased 
significantly  (P  <  0.001)  when  0.25,  0.50,  or  1.0  mM  cAMP  was  added.  MTg 
concentrations that could be measured in the culture supernatants were significantly 
increased  by  the  addition  of 0.50  and  1.0  mM  cAMP,  compared  with  0.25  mM 
(P<  0.010)  or no cAMP (P<  0.001). 
To determine if MTg yields could be further increased, the combined use of cAMP 
and  TSH  was  compared  with  that  of TSH  alone.  Because  thyroid cells optimally 
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FIG.  1.  Amounts of MTg in the supernatant  (--) and in the extract of cells (- • .) from primary 
CBA thyroid cells cultured at different concentrations of cAMP. MTg concentration was determined 
on day 3 by comparing  extinction  values from three  to five dilutions  per sample  (vertical bars 
indicate standard deviations) with an MTg standard curve in the ELISA. PAULA CREEMERS,  NOEL R.  ROSE,  AND YI-CHI  M.  KONG  563 
form monolayers between days 5 and 7, we obtained supernatant samples sequentially 
on days 3, 6, and 9 of culture. After each sampling, the cells were washed twice before 
fresh  medium  was  added.  Again,  five wells were  pooled and  the  amounts  of MTg 
were determined.  Fig. 2 indicates that the addition of TSH alone enabled MTg to be 
produced  at  a  low  level  up  to  day  3  (graph  A).  However,  combined  with  1 mM 
cAMP, TSH markedly increased the amount and duration of MTg production (up to 
9  d);  it was still  effective at  a  dose of 31  ~U/ml.  Thus, 60/~U TSH/ml  and  1 mM 
cAMP  were  routinely  added  to  propagate  thyroid  target  cells  for the  cytotoxicity 
assay. Because the amount of MTg produced gradually decreased during the culture 
period,  we  used  the  target  cells  no  later  than  7  d  in  culture.  At  this  time,  the 
monolayer was confluent and usually contained no more than 20% fibroblasts. 
Generation of Effector Cells Cytotoxic  for Thyroid Monolayers.  Previous studies from our 
laboratory  (7,  8)  have  shown  that  LNC  from  immunized  good  responder  mice 
proliferate in vitro in the presence of MTg. Thymidine uptake was optimal on day 5 
after stimulation with MTg doses of 25-50 ~g/ml  (8). Furthermore,  the proliferative 
response appeared  to be an early in vitro correlate of lymphocyte infiltration,  which 
is  the  effector phase  of autoimmune  thyroiditis.  To  generate  effector cells,  we first 
cultured  LNC  on  day  12  after  immunization  with  10,  25,  or 50/Lg MTg/ml,  and 
measured their cytotoxicity for lnIn-labeled thyroid cells in a  16-h assay on days 4, 5, 
and 6 of culture. The cytotoxic response was very similar when measured on day 5 or 
6  (35  vs.  34%  and  63  vs.  75%  on two occasions), but  none was observed on day 4. 
Cytotoxicity was  usually  demonstrable  when  LNC were cultured  with  10 or 25 /xg 
MTg/ml. We next determined the optimal effector cell concentration with a standard 
monolayer  of thyroid  target  cells  in  the  cytotoxic  reaction.  Specific  rain-release 
increased in proportion to the number of effector cells added, up to -3  ×  105 per well 
(Fig.  3).  This titration  led us to select  a  dose of 2  ×  105 effector cells in subsequent 
experiments. 
Specificity  of the  generation  of in  vitro  cytotoxicity  for  thyroid  cells  was  next 
investigated; a representative experiment is presented in Table I. No cytotoxicity was 
observed when  LNC from mice immunized with  MTg were cultured  with  25 or 50 
fig BSA/ml  instead  of MTg,  or when  LNC derived  from animals  immunized  with 
saline  and  CFA were cultured  with  10 or 25 ~g MTg/ml.  The strain  used  for the 
E  4  . 
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FIo. 2.  Amounts of MTg in the supernatant  of primary CBA thyroid cell cultures at different 
concentrations of thyroid-stimulating hormone with (0) or without (ik) 1 mM of cAMP. Samples 
were obtained on day 3 (A), 6 (B), or 9 (C) of euhure. MTg concentrations were determined by 
means of the ELISA, as indicated in the legend to Fig. l. 564  CYTOTOXIC  T  CELLS  ON  THYROID  MONOLAYERS 
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Fro.  3.  Relationship between percent specific rain-release from a standard CBA thyroid monolayer 
and increasing concentrations of effector cells. LNC were obtained from MTg-immunized mice and 
stimulated  in  vitro  with  10  /tg  MTg/ml  for 5  d.  Vertical  bars  indicate  standard  deviations  of 
quadruplicates. 
TABLE  I 
Cell-mediated Cytotoxicity  for Thyroid Cultures by Lymphocytes  from Immumzed CBA 
Mice after In  Vitro Stimulation with MTg* 
Percent specific  rain- 
release -  SD from 
Immunization  Antigen added to  culture  thyroid target cells 
CBA  BALB/c 
120/~g MTg in CFA  10/~g MTg/ml  34 +  9  3-- 4 
25/~g MTg/ml  85 +-  12  ND$ 
50 #g MTg/ml  57 -  10  3 +- 8 
25/Lg BSA/ml  9 +  5  0 -+ 3 
50/tg BSA/ml  14 -  10  1  _  1 
Saline in CFA  10/~g MTg/ml  2 -  1  ND 
25/~g MTg/ml  8 +  5  ND 
* LNC were collected on day 14 after immunization and were incubated in vitro with 
MTg or BSA.  Cytotoxicity was measured on day 5 of culture. 
$ Not determined. PAULA CREEMERS,  NOEL R.  ROSE,  AND  YI-CHI  M.  KONG 
TABLE II 
MTg Specificity of the Cytotoxic Response of Immune CBA LNC* 
565 
Percent specific 
Series  Antigen added  Thyroid target cell preincubation  lnln-release + 
to culture  SD:~ 
A  10 #g MTg/ml 
B  25 #g MTg/ml 
Normal rabbit serum  44 ±  10 
Rabbit anti-MTg serum  9 ± 6 
Rabbit anti-MTg serum absorbed with MTg-coated  63 ±  15 
erythrocytes 
Rabbit anti-MTg serum absorbed with CBA spleen  2 ± 4 
cells 
* LNC were obtained on day 12 after immunization with 120 #g MTg in CFA. Cytotoxicity was performed 
on day 5 of culture with MTg. 
:[: Numbers are averages of two identical experiments with similar values of maximal cytotoxicity. The 
differences between experimental and control values were statistically significant (P < 0.010) within each 
experiment before the results were pooled. 
thyroid  target  cells  was  also  important:  LNC  from  CBA  mice  were  cytotoxic  for 
labeled target cells from syngeneic, but not allogeneic (BALB/c), thyroids. 
The need for MTg in antigen recognition by immune lymphocytes in the generation 
and expansion  of cytotoxic cells also applied  to target cell  destruction.  As shown in 
Table  II, preincubation  of rain-labeled  thyroid  monolayers with  rabbit  anti-MTg 
serum  (1:100)  blocked  the  cytotoxic  reaction  (series  A).  The  blocking  activity  of 
antibodies to MTg was removed by absorption with MTg-coated erythrocytes, which 
restored cytotoxicity to 63% (series B). In contrast, blocking activity was retained after 
absorption  with  CBA spleen  cells,  an  indication  that  inhibition  of cytotoxicity was 
not due to the possible presence of antibodies  to murine  H  antigens.  These findings 
show  that  the  cytotoxic reaction  depends  upon  recognition  by the  effector cells  of 
MTg determinants  expressed on the thyroid cell membrane. 
Characterization  of Cytotoxic Effector  Cells.  We have shown above that immune CBA 
LNC stimulated in vitro with MTg became cytotoxic for syngeneic but not allogeneic 
thyroid target cells. The Ho2 requirement in syngeneic cell killing was then studied by 
pretreatment  of thyroid monolayers with  monospecific alloantisera  to the K s  (1:40) 
and D k (1:20) regions. Table III shows that incubation with either anti-K s or anti-D k 
serum  resulted  in  ~50%  reduction  in  cytotoxicity (28-31%  rain-release),  compared 
with treatment with normal mouse serum  (66% rain-release).  When target cells were 
preincubated  with  anti-K s  and anti-D * sera combined, cytotoxicity was completely 
abolished. 
To  determine  the  surface  antigens  of the  cytotoxic  LNC,  aliquots  of 2  ×  107 
immune  cells  that  had  been  cultured  with  MTg  were  incubated  with  monoclonal 
antibodies  to Thy-1.2, Lyt-1.1, or Lyt-2.1, and complement just  before the cytotoxic 
test was performed (day 5 of culture). Rabbit anti-mouse Ig was used as an amplifier. 
To determine whether cells of different Lyt type played a role, similar treatment with 
antisera was performed on day 4 of culture, when no cytotoxicity was detectable. The 
latter  cells  were  subsequently  cultured  for  another  day,  so  that  cytotoxicity  was 
measured  on day 5.  Control  LNC  (treated  with  rabbit  antiserum  to mouse Ig and 
complement only) were counted, and diluted in cytotoxicity medium to 2 ×  10S/well 
for the eytotoxicity assay.  Because all  samples  contained  the same number of LNC 566  CYTOTOXIC  T  CELLS  ON  THYROID  MONOLAYERS 
TABLE  III 
H-2 Requirement of Cytotoxic Response of LNC from Immunized CBA Mice 
after Stimulation  In  Vitro by Culture with MTg* 
Target cell preincubation 
Percent specific  HlIn- 
release ±  SD~ from 
thyroid target cells 
CBA  BALB/c 
Normal mouse serum  66 ±  1 
Mouse anti-H-2K  k  31 ±  4 
Mouse anti-H-2D  k  28 ±  2 
Mouse anti-H-2K  k +  anti-H-2D  k  1 ±  4 
3±4 
* LNC were obtained on day 14 after immunization with 120 #g MTg in CFA. 
Cytotoxicity was performed on day 5 of culture with MTg. 
Numbers are averages from two identical experiments with similar values for 
percent cytotoxicity in normal mouse serum controls. The differences be- 
tween experimental and control values were  statistically significant  (P < 
0.010) within each experiment before the results were pooled. 
TABLE  IV 
Influence of Killing Immune  LNC Subsets on Day 4 or 5 after Culture with 
MTg on the Cytotoxic Reaction on Day 5 
Treatment 
Percent specific rain-release + 
SD* from thyroid target cells 
Day 4  Day 5 
Anti-Thy-l.2, rabbit anti-mouse Ig, and  9 +  13  9 ±_ 7 
complement 
Anti-Lyt-l.1, rabbit anti-mouse Ig, and  6 +  6  57 ±  18 
complement 
Anti-Lyt-2.1, rabbit anti-mouse Ig, and  56 ±  6  4 ±  6 
complement 
Rabbit anti-mouse Ig and complement  64 ±  17  62 ±  13 
* Numbers are averages of three experiments (day 4) or two experiments (day 
5) pooled on the basis of statistically significant differences (P <  0.010) within 
each experiment. Experiments were selected on the basis of similar percent 
cytotoxicity in control cultures (treatment with rabbit anti-mouse Ig and 
complement only). 
before  antiserum  treatment,  the  LNC,  depleted  of subsets,  were  diluted  in  volumes 
identical to the control sample. 
Table  IV shows that  the cytotoxic  cells were Thy-1 +  and  Lyt-2 +.  Treatment  with 
Lyt-2.1,  but  not  Lyt-l.1,  antibodies just  before  the  cytotoxic  assay  was  performed 
(day  5  of culture)  prevented  the cytotoxic  response.  In contrast,  treatment  on day  4 
with Lyt-2.1  antibody  and complement  24 h  before the cytotoxic assay was performed 
did not abolish the cytotoxic response, whereas treatment  with anti-Lyt-1.1  antibody 
and complement  did. Thus, despite further incubation  in culture after the elimination 
of Lyt- 1-bearing subsets, cytotoxic cells were not generated. 
Discussion 
The  data  above show that  LNC  from MTg-immunized  mice became  cytotoxic for 
thyroid  monolayers  after  in  vitro  culture  with  MTg  and  that  the  effector  cells  are PAULA CREEMERS, NOEL R.  ROSE, AND YI-CHI M.  KONG  567 
Lyt-2-bearing T  cells. In the course of these studies, our first concern was to establish 
functional thyroid cell cultures with a  suitable label for assessing target cell destruc- 
tion. We elected to monitor MTg production as a  measure of thyroid function  (21) 
rather than iodide uptake (19, 20) or the release of thyroid hormones (20), reasoning 
that, as the autoantigen in question, MTg on the thyroid membrane would provide 
the necessary epitopes for the effector cells. To determine whether MTg found in the 
supernatant represented newly synthesized protein or the release of preformed protein, 
cell extracts were also assayed for MTg content. It is apparent that the MTg found in 
the 3-d supernatant of thyroid cells cultured in the presence of cAMP  (-----  0.50 mM) 
was at least in part newly synthesized, because at lower concentrations of cAMP, the 
supernatants contained much less MTg and the amounts recoverable from the cells 
fell precipitously (Fig. 1). It is not known if, in the absence of cAMP, MTg production 
ceased early during the 3-d period or never occurred. When varying concentrations of 
TSH were added  in  combination with  1 mM cAMP,  the  amounts  of MTg in  the 
medium  increased  markedly and  production  continued  for 9  d  (Fig.  2).  When  no 
cAMP was  included,  varying the concentration  of TSH exerted  little  influence on 
MTg synthesis.  Because confluent  monolayers of thyroid culture were observed by 
days 5-7 and were suitable for use as target cells,  they were functional  in terms of 
MTg production at the time of the cytotoxicity assay. 
Specificity of the cytotoxic response of LNC for MTg was tested at both the effector 
and target cell level. Generation and expansion of cytotoxic clones were observed only 
when MTg was added to the culture medium but not when BSA was used (Table I). 
LNC  from  saline-injected  mice  did  not  develop  cytotoxic  cells  in  culture  in  the 
presence of MTg. Cytotoxicity for thyroid targets was blocked by their pretreatment 
with  rabbit  antiserum  to  MTg  (Table  II). The  blocking activity was  removed by 
absorption  with  MTg-coated  erythrocytes  but  not  with  CBA  spleen  cells,  which 
indicates that the blockade was not caused by the possible presence of antibodies to 
H  antigens  of the  mouse.  Thus,  the  immune  LNC  recognize  MTg in  both  clonal 
expansion and target cell destruction. 
However, MTg determinants  alone on the target cells are insufficient  to initiate 
killing  by activated  LNC.  BALB/c  thyroid  monolayers labeled  with  rain  are  not 
destroyed by MTg-stimulated LNC from CBA mice. This H-2 restriction was verified 
by finding antisera to K k and D k regions inhibitory to the c),totoxic response (Table 
III). Each antiserum could reduce rain-release by ~50%, whereas their combined use 
led to total inhibition. Thus, both K and D  molecules serve as restriction elements in 
target cell killing. The need for K  and D  region recognition resembles the cytotoxic 
responses of effector T  cells to tumor and other modified self-antigens  (22)  and has 
been reported in producing lesions in immunized mice given thyroid transplants (23). 
Characterization of the cytotoxic cells shows that they and their precursors are Thy- 
1-bearing  T  cells.  By  day  5  of culture,  these  effector  T  cells  express  the  Lyt-2 
phenotype  (Table IV), and the cytotoxic response observed on either day 5  or 6  is 
similar  in  magnitude.  In  contrast,  on  day  4  of culture,  cytotoxicity  was  not  yet 
measurable. The effector LNC were not removed by killing with Lyt-2 antibodies at 
this stage, which suggests that most cytotoxic cells were still in their undifferentiated 
state.  Yet  when  the  LNC  were exposed  to  Lyt-I  antibodies  on  day 4,  no  further 
cytotoxic response was observed on day 5.  These findings  suggest that,  although T 568  CYTOTOXIC T  CELLS ON THYROID  MONOLAYERS 
cell clones cytotoxic to thyroid monolayers are Lyt-2  +,  they require the presence of 
Lyt- 1  + (Lyt- 123 +) cells for their expansion and/or differentiation. 
The absence of detectable cytotoxicity in the popliteal and inguinal  LNC during 
the early culture  period  appears to  reflect  the  in  vivo state.  LNC  and  spleen  cells 
removed between days 12 and 23 after immunization and tested without prior culture 
with  MTg were not  cytotoxic  (unpublished  observations). The results  suggest  that 
sensitized T  cells leave these lymph nodes and spleen once they have differentiated to 
a  certain  stage, whereas  their precursors committed to MTg remain  (at  least  for a 
period  of time).  This interpretation  accords with  our previous report  that  optimal 
proliferative response to MTg occurs in popliteal LNC obtained on days 8-14 after 
immunization,  declining by days 21-28  (8).  It  is  also possible that  suppressor cells 
that interfere with responses to MTg develop between 2 and 3 wk after immunization 
but die during culture, thereby permitting cytotoxic clones to develop in vitro. This 
possibility is under study. 
To our knowledge, this study represents the first direct demonstration in vitro of a 
T  cell  effector mechanism  in  EAT.  Thyroid-specific T  cells  have been reported  to 
effect EAT in various animal transfer systems (24-26),  two of which involve prior in 
vitro culture for 3 d with thyroglobulin (25) or thyroid monolayers (26).  Such transfers 
into normal recipients, which lead to thyroid damage, may involve the recruitment of 
host cytotoxic clones and/or contain donor cytotoxic precursor cells. Although  these 
studies  implicate T  cells in EAT, they do not  yet explain how damage eventuates. 
The in vitro cytotoxic system described herein  permits the dissection of the steps in 
cellular  differentiation  and  the  precise  identification  of effector cells.  Moreover,  it 
may facilitate the study of regulatory mechanisms such as the D-end modulation of 
thyroiditis reported by us earlier (14). 
Whether the present observation of cytotoxic mechanisms in EAT is applicable to 
human  thyroiditis  remains  to  be determined.  Thyroid  membrane molecules other 
than thyroglobulin may serve as additional autoantigens. As yet, the effector mecha- 
nisms that lead to thyroid damage in the human are unclear, despite ample evidence 
for  autoimmune  responses.  This  evidence  includes  (a)  sensitized  T  cells  in  the 
peripheral blood, which can either reduce iodide uptake by cultured thyroid cells (27) 
or kill  antigen-coated  mastocytoma cells  (28),  (b)  antigen-specific  T  cells  (29)  and 
plaque-forming cells in the thyroid  (30), and  (c) circulating antibodies to more than 
one thyroid antigen.  Some of the antibodies have been shown to mediate antibody- 
dependent  cellular cytotoxicity for thyroglobulin-coated erythrocytes  (31).  For each 
response,  however,  it  remains  difficult  to  distinguish  between  cause  and  effect  of 
thyroid  damage.  On  the  basis  of our  present  study,  it  is  clear  that  direct  T  cell 
cytotoxicity may be one prime effector mechanism. 
Summary 
Effector mechanisms in experimental autoimmune thyroiditis  (EAT) were studied 
in vitro by establishing a  cytotoxicity system with thyroid target cells.  Lymph node 
cells  (LNC)  from popliteal  and  inguinal  lymph nodes  were obtained  from CBA/J 
mice  (8-10 wk old)  12-18  d  after immunization  with  120 #g mouse thyroglobulin 
(MTg) in complete Freund's adjuvant (0.2 ml to both hind footpads and thighs) and 
were cultured with MTg (10-50/~g/ml). On day 5 of culture, viable LNC were added 
to labeled thyroid monolayers and their cytotoxicity was assayed after 16 h. Functional PAULA CREEMERS,  NOEL  R.  ROSE,  AND YI-CHI M.  KONG  569 
thyroid target cells, as reflected by MTg  production for up to 9 d, were prepared by 
adding  1 mM  dibutyryl adenosine  3',5'-cyclic monophosphate  and  60  #U  thyroid- 
stimulating hormone/ml to the culture medium. On days 5-7, confluent monolayers 
were labeled with  1HIn and used as targets. Specific rain-release ranged  from  56  to 
85%. 
The cytotoxic response is MTg specific and H-2 restricted. Pretreatment of thyroid 
target cells with rabbit antiserum to MTg completely inhibited cytotoxicity. Pretreat- 
ment with mouse antiserum to either K k or D k products resulted in ~50% inhibition, 
whereas the combined use of both antisera led to total inhibition. No cytotoxicity was 
observed when control BALB/c thyroid cultures were the target cells. The kinetics of 
the expansion of Thy-1 + cytotoxic cells by in vitro exposure to MTg were then studied. 
The cytotoxic response required 5  d  to develop and was abolished by treating LNC 
on day 4 with monoclonal antibody to Lyt-1.1, but not to Lyt-2.1, plus complement. 
In contrast, by day 5, cytotoxicity was abrogated by similar treatment with antiserum 
to Lyt-2.1, but  not  to Lyt-1.1. We conclude that cytotoxic cells derived from  MTg- 
immunized  mice  are  Lyt-2-bearing cells but  require  the  presence  of Lyt-l-bearing 
cells for their generation and/or differentiation. 
We sincerely thank Dr. Mark Lewis for his help and discussion. 
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